Announcements Trials
Browse Landscape

Status

Completed 7Active not recruiting 5Unknown 2Recruiting 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 15Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 2Rhabdoid Tumor 2Wilms Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Neoplasms, Castration-Resistant 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Pinealoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Disease 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Sarcoma, Synovial × Genitourinary × Clear all
NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available
GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡